Sign In to Follow Application
View All Documents & Correspondence

Synthesis Of Nanoparticles Of Chromium Oxide Using Plant Extract Through Dmso (Dimethyl Sulfoxide)

Abstract: ABSTRACT Synthesis of nanoparticle of chromium oxide using plant extract through DMSO {Dimethyl Sulfoxide) solvent is a method of synthesizing chromium oxide nanoparticles, comprising the steps of providing a solution ofchromium ions & providing plant extract solution and combining the chromium ion solution and the plant extract solution while stirring at a temperature of 40° C to produce the chromium oxide nanoparticles. In where Chromium nitrate nonhydrate (Cr(N03)3.9H20 ) used as a chromium ion source, DMSO used as a solvent and plant extract used as a reducing agent, Incubation period results in a change of color of the mixture to Black which is a visual confirmation of the synthesized MPs. Further, synthesized nanoparticles are further characterized using Scanning Electron Microscopy (SEM). .Fig 1

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
10 July 2019
Publication Number
31/2019
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2024-06-03
Renewal Date

Applicants

BIOFAC INPUTS PRIVATE LIMITED
Unit 1, Plot No. 74C, Anrich Industrial Estate IDA Bollaram, Hyderabad, Telangana, India-502325.

Inventors

1. MR. LAXMI NARAYAN REDDY
Unit 1, Plot No. 74C, Anrich Industrial Estate IDA Bollaram, Hyderabad, Telangana, India-502325.

Specification

We CLAIM
1. A method of synthesizing chromium oxide nanoparticles, comprising the steps of providing a solution of chromium ions & providing plant extract solution and combining the chromium ion solution and the plant extract solution while stirring at a temperature of 40° C to produce the chromium oxide nanoparticles.
2. The method of synthesizing chromium oxide nanoparticles according to claim 1, where Chromium nitrate nonhydrate(Cr(N03)3.9H20 ) used as a chromium ion source.
3. The method of synthesizing chromium oxide nanoparticles according to claim 1, where DMSO used as a solvent.
4. The method of synthesizing chromium oxide nanoparticles according to claim 1, where unknown plant extract used as a reducing agent.
5. The method of synthesizing chromium oxide nanopartictes according to claim 1, wherein said chromium oxide nanoparticles have a mean diameter in the range from about 89 to about 97 nm.

Documents

Application Documents

# Name Date
1 Form9_Earlier Publication_10-07-2019.pdf 2019-07-10
2 Form2 Title Page_Complete_10-07-2019.pdf 2019-07-10
3 Form18_Normal Request_10-07-2019.pdf 2019-07-10
4 Form 3_As Filed_10-07-2019.pdf 2019-07-10
5 Form 1_As Filed_10-07-2019.pdf 2019-07-10
6 Drawing_As Filed_10-07-2019.pdf 2019-07-10
7 Description Complete_As Filed_10-07-2019.pdf 2019-07-10
8 Correspondence by Applicant_As Filed_10-07-2019.pdf 2019-07-10
9 Claims_As Filed_10-07-2019.pdf 2019-07-10
10 Abstract_As Filed_10-07-2019.pdf 2019-07-10
11 IMPORTANT LETTER FROM NBA.pdf 2019-12-06
12 201941027575-FER.pdf 2021-10-17
13 201941027575-RELEVANT DOCUMENTS [19-03-2022(online)].pdf 2022-03-19
14 201941027575-PETITION UNDER RULE 138 [19-03-2022(online)].pdf 2022-03-19
15 201941027575-PETITION UNDER RULE 137 [19-03-2022(online)].pdf 2022-03-19
16 201941027575-OTHERS [19-03-2022(online)].pdf 2022-03-19
17 201941027575-FER_SER_REPLY [19-03-2022(online)].pdf 2022-03-19
18 201941027575-DRAWING [19-03-2022(online)].pdf 2022-03-19
19 201941027575-CORRESPONDENCE [19-03-2022(online)].pdf 2022-03-19
20 201941027575-COMPLETE SPECIFICATION [19-03-2022(online)].pdf 2022-03-19
21 201941027575-CLAIMS [19-03-2022(online)].pdf 2022-03-19
22 201941027575-ABSTRACT [19-03-2022(online)].pdf 2022-03-19
23 201941027575-NBA Approval Submission [12-09-2022(online)].pdf 2022-09-12
24 201941027575-Response to office action [10-04-2023(online)].pdf 2023-04-10
25 201941027575-US(14)-HearingNotice-(HearingDate-12-12-2023).pdf 2023-11-06
26 201941027575-FORM-26 [07-11-2023(online)].pdf 2023-11-07
27 201941027575-FORM-26 [28-11-2023(online)].pdf 2023-11-28
28 201941027575-Correspondence to notify the Controller [08-12-2023(online)].pdf 2023-12-08
29 201941027575-Annexure [08-12-2023(online)].pdf 2023-12-08
30 201941027575-Written submissions and relevant documents [27-12-2023(online)].pdf 2023-12-27
31 201941027575-Written submissions and relevant documents [27-12-2023(online)]-2.pdf 2023-12-27
32 201941027575-Written submissions and relevant documents [27-12-2023(online)]-1.pdf 2023-12-27
33 201941027575-Response to office action [27-12-2023(online)].pdf 2023-12-27
34 201941027575-Response to office action [27-12-2023(online)]-1.pdf 2023-12-27
35 201941027575-RELEVANT DOCUMENTS [27-12-2023(online)].pdf 2023-12-27
36 201941027575-POA [27-12-2023(online)].pdf 2023-12-27
37 201941027575-MARKED COPIES OF AMENDEMENTS [27-12-2023(online)].pdf 2023-12-27
38 201941027575-FORM 13 [27-12-2023(online)].pdf 2023-12-27
39 201941027575-Annexure [27-12-2023(online)].pdf 2023-12-27
40 201941027575-Annexure [27-12-2023(online)]-2.pdf 2023-12-27
41 201941027575-Annexure [27-12-2023(online)]-1.pdf 2023-12-27
42 201941027575-AMMENDED DOCUMENTS [27-12-2023(online)].pdf 2023-12-27
43 201941027575-RELEVANT DOCUMENTS [30-12-2023(online)].pdf 2023-12-30
44 201941027575-PETITION UNDER RULE 137 [30-12-2023(online)].pdf 2023-12-30
45 201941027575-NBA Approval Submission [01-06-2024(online)].pdf 2024-06-01
46 201941027575-NBA Approval Submission [01-06-2024(online)]-1.pdf 2024-06-01
47 201941027575-PatentCertificate03-06-2024.pdf 2024-06-03
48 201941027575-IntimationOfGrant03-06-2024.pdf 2024-06-03

Search Strategy

1 SearchStrategy201941027575E_31-08-2021.pdf

ERegister / Renewals

3rd: 23 Aug 2024

From 10/07/2021 - To 10/07/2022

4th: 23 Aug 2024

From 10/07/2022 - To 10/07/2023

5th: 23 Aug 2024

From 10/07/2023 - To 10/07/2024

6th: 23 Aug 2024

From 10/07/2024 - To 10/07/2025

7th: 23 Aug 2024

From 10/07/2025 - To 10/07/2026

8th: 23 Aug 2024

From 10/07/2026 - To 10/07/2027

9th: 23 Aug 2024

From 10/07/2027 - To 10/07/2028

10th: 23 Aug 2024

From 10/07/2028 - To 10/07/2029